• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型彩色视野计在有和无葡萄糖功能障碍人群中的重复性。

Repeatability of a novel chromatic perimeter in a cohort of people with and without glucose dysfunction.

作者信息

Owusu-Afriyie Bismark, Wu Christopher S, Burhans Liam, Coates Daniel R, Harrison Wendy W

机构信息

University of Houston College of Optometry, Houston, Texas.

出版信息

Optom Vis Sci. 2025 Sep 1;102(9):578-585. doi: 10.1097/OPX.0000000000002285. Epub 2025 Aug 5.

DOI:10.1097/OPX.0000000000002285
PMID:40690734
Abstract

SIGNIFICANCE

Sensitive diagnostic techniques are crucial for the early detection of diabetes. Here, we tested a novel color perimeter and found it repeatable in control subjects. It also has the potential to detect functional changes in diabetic eye disease.

PURPOSE

Type 2 diabetes (T2DM) causes retinal dysfunction before the appearance of retinopathy. Our group developed a color perimeter that measures chromatic sensitivity at discrete retinal locations. This study evaluates the repeatability of this perimeter in detecting chromatic sensitivity changes in normal and glucose-dysfunctional states.

METHODS

Eighteen subjects, 49.4 (7.8) years, nine controls (HbA1c ≤5.6%), nine with glucose dysfunction (HbA1c ≥5.7%, no/mild retinopathy), participated. Congenital color defects, diseases affecting color vision, vision >20/32, and those with tinted glasses were excluded. Visual acuity, L'Anthony D-15, and color perimetry were performed at two visits within 9 months. Lens and fundus photographs were taken. Chromatic thresholds were measured at four diagonal locations 3° from fixation in the right eye using 0.5° diameter red, green, blue, and yellow stimuli through a randomly interleaved staircase method. Thresholds were converted to log cone contrast and averaged. The test-retest repeatabilities were analyzed using Bland-Altman plots. Trends were analyzed using linear regression, and Wilcoxon matched-pairs signed rank test and t tests for comparisons.

RESULTS

Clinical tests did not differ between visits (all p ≥ 0.05). Bland-Altman control group plots showed bias lines and measurement differences near zero for all colors (all p > 0.53). Trend lines were horizontal and near zero for all colors (all p > 0.22). In the glucose dysfunction group, the mean of measurement differences was not significantly different from zero for all colors (all p > 0.13). However, green, blue, and yellow stimuli had significant or trending negative-sloped trend lines (p = 0.03, 0.04, and 0.06, respectively). Detailed review of individual clinical data revealed that subjects with relatively longer duration of T2DM, higher HbA1c, and/or mild retinopathy often performed worse on their second visit.

CONCLUSIONS

The novel color perimeter demonstrated both good repeatability and potential for detecting subtle visual changes due to glucose dysfunction. Further testing is necessary to compare performance with other structural and functional tests.

摘要

意义

灵敏的诊断技术对于糖尿病的早期检测至关重要。在此,我们测试了一种新型彩色视野计,发现其在对照受试者中具有可重复性。它还有潜力检测糖尿病眼病中的功能变化。

目的

2型糖尿病(T2DM)在视网膜病变出现之前就会导致视网膜功能障碍。我们团队开发了一种彩色视野计,可测量视网膜离散位置的色觉敏感度。本研究评估了该视野计在检测正常和糖代谢功能异常状态下色觉敏感度变化方面的可重复性。

方法

18名受试者,年龄49.4(7.8)岁,9名对照者(糖化血红蛋白≤5.6%),9名糖代谢功能异常者(糖化血红蛋白≥5.7%,无/轻度视网膜病变)参与研究。排除先天性色觉缺陷、影响色觉的疾病、视力>20/32者以及戴有色眼镜者。在9个月内进行两次视力、L'Anthony D-15和彩色视野检查。拍摄晶状体和眼底照片。使用0.5°直径的红色、绿色、蓝色和黄色刺激物,通过随机交错阶梯法,在右眼距注视点3°的四个对角位置测量色觉阈值。将阈值转换为对数视锥细胞对比度并求平均值。使用Bland-Altman图分析重测可重复性。使用线性回归分析趋势,并使用Wilcoxon配对符号秩检验和t检验进行比较。

结果

两次检查之间的临床测试无差异(所有p≥0.05)。Bland-Altman对照组图显示所有颜色的偏差线和测量差异均接近零(所有p>0.53)。所有颜色的趋势线均为水平且接近零(所有p>0.22)。在糖代谢功能异常组中,所有颜色的测量差异平均值与零无显著差异(所有p>0.13)。然而,绿色、蓝色和黄色刺激物有显著或呈负斜率的趋势线(分别为p = 0.03、0.04和0.06)。对个体临床数据的详细审查显示,T2DM病程相对较长、糖化血红蛋白较高和/或有轻度视网膜病变的受试者在第二次检查时通常表现较差。

结论

新型彩色视野计显示出良好的可重复性以及检测因糖代谢功能异常引起的细微视觉变化的潜力。需要进一步测试以将其性能与其他结构和功能测试进行比较。

相似文献

1
Repeatability of a novel chromatic perimeter in a cohort of people with and without glucose dysfunction.一种新型彩色视野计在有和无葡萄糖功能障碍人群中的重复性。
Optom Vis Sci. 2025 Sep 1;102(9):578-585. doi: 10.1097/OPX.0000000000002285. Epub 2025 Aug 5.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.光学相干断层扫描(OCT)用于检测糖尿病视网膜病变患者的黄斑水肿。
Cochrane Database Syst Rev. 2015 Jan 7;1(1):CD008081. doi: 10.1002/14651858.CD008081.pub3.
4
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.抗血管内皮生长因子治疗糖尿病性黄斑水肿:一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD007419. doi: 10.1002/14651858.CD007419.pub5.
5
Trifocal versus extended depth of focus (EDOF) intraocular lenses after cataract extraction.白内障摘除术后三焦点与扩展景深(EDOF)人工晶状体的比较。
Cochrane Database Syst Rev. 2024 Jul 10;7(7):CD014891. doi: 10.1002/14651858.CD014891.pub2.
6
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较:系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
7
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.1型糖尿病强化血糖控制与传统血糖控制的比较
Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2.
8
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.抗血管内皮生长因子治疗增殖性糖尿病视网膜病变
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008721. doi: 10.1002/14651858.CD008721.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.